Home/Pipeline/Monoclonal Antibodies

Monoclonal Antibodies

Oncology, Autoimmune

Pre-clinicalR&D

Key Facts

Indication
Oncology, Autoimmune
Phase
Pre-clinical
Status
R&D
Company

About Tiantan Bio

Tiantan Bio is a major player in China's biopharmaceutical sector, with a core focus on plasma-derived therapeutics and vaccines. As part of the Sinopharm Group ecosystem, it benefits from significant scale and strategic importance in public health. The company leverages its extensive plasma collection network and manufacturing capabilities to serve the large domestic market, with a pipeline that includes both biosimilars and novel biological products.

View full company profile